Non-negotiable editorial rules

  1. We do not publish content on defeating, evading, adulterating, or cheating a drug test. This explicitly excludes: synthetic or fake urine, detox or "flush" products marketed to beat tests, dilution and adulteration techniques, "how to pass in 24 hours" guidance, device tampering, and temperature spoofing.
  2. Every health or compliance page is sourced. We use primary regulatory and clinical references (SAMHSA, DOT, ASAM, FDA, peer-reviewed literature). Gray-market sources are not cited.
  3. Clinical content is medically reviewed. Pages covering clinical interpretation, MRO process, or testing procedure are reviewed by an AAMRO-certified Medical Review Officer before publication.
  4. We do not give medical, legal, or HR advice. We describe what regulations and clinical consensus say; we point readers to qualified professionals (MROs, clinicians, employment counsel) for decisions specific to their situation.
  5. Recovery content surfaces support. Pages covering substance use prominently include the SAMHSA National Helpline (1-800-662-HELP / 4357) and frame results supportively, never punitively.

Sourcing standards

Each clinical or compliance article cites at least two primary sources. Acceptable primary sources include:

  • Federal regulations (49 CFR Part 40, SAMHSA Mandatory Guidelines, applicable state statutes).
  • Government agency publications (SAMHSA, DOT, FDA, CDC, HHS).
  • Peer-reviewed clinical and analytical chemistry journals.
  • Professional society guidance (ASAM, AAMRO, MROCC, AMA, AAFP, AAP).

Unacceptable sources include: blog posts on commercial test-kit or "detox product" sites, marketing claims by test vendors not corroborated by independent literature, social media content, and any source whose primary purpose is selling a product or service to defeat a test.

Freshness

Every editorial page carries a Last updated date. Substance pages, panel pages, and workplace compliance pages are reviewed at least annually and following any significant regulatory change (e.g., the July 7, 2025 fentanyl addition to the federal panel). Detection-window data is updated when new primary-source guidance is published.

Bylines and medical review

Articles are written by named authors and, for clinical content, reviewed by a named medical reviewer. Author and reviewer profiles include credentials, professional background, and sameAs links to verified profiles where available. See the team.

Corrections

We aim to be specific, accurate, and current. When we are wrong — whether on a fact, a citation, an inference, or a date — we want to know. drugtest.co is pre-launch and the site itself is offered for sale via Escrow.com; once acquired, the new operator will publish a corrections channel on the contact page. The five-business-day correction window applies from that point forward.

Significant editorial updates carry a visible "updated" note with the date and a short explanation of what changed.

Conflicts of interest and monetization

drugtest.co does not sell tests, collect specimens, run a laboratory, employ MROs, or have a financial stake in any specific testing provider. Our editorial team and medical reviewers do not endorse products or providers.

Where the site displays affiliate, sponsored, or advertising content in the future, those placements will:

  • Carry visible disclosure consistent with FTC guidance.
  • Be editorially separated from reference content.
  • Be subject to the same editorial guardrail — no gray-market products.

Use of AI

Editorial content is written by humans, reviewed by humans, and signed off by named medical reviewers. We use AI tools as drafting aids and for editorial QA (e.g., consistency checks across pages, sourcing audits). Every published page is reviewed by a human author and, where applicable, a medical reviewer.